Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval

Sharon E Moayeri; Steven E Coutre; Edward J Ramirez; Lynn M Westphal

doi:10.1016/j.ajog.2007.01.025

Von Willebrand disease presenting as recurrent hemorrhage after transvaginal oocyte retrieval

Am J Obstet Gynecol. 2007 Apr;196(4):e10-1. doi: 10.1016/j.ajog.2007.01.025.

Authors

Sharon E Moayeri¹, Steven E Coutre, Edward J Ramirez, Lynn M Westphal

Affiliation

¹ Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Stanford Hospital, Stanford, CA, USA.

PMID: 17403383
DOI: 10.1016/j.ajog.2007.01.025

Abstract

A 34-year-old nulligravid woman experienced hemorrhage after each of 2 oocyte retrievals. Initial coagulopathy screening was negative. Treatments used during in vitro fertilization likely interfered with assay performance. Reevaluation remote from medications confirmed the diagnosis of von Willebrand disease. Treatments used during in vitro fertilization may increase bleeding risk and confound coagulopathy evaluation.

Publication types

Case Reports

MeSH terms

Adult
Diagnosis, Differential
Female
Fertilization in Vitro / adverse effects*
Fertilization in Vitro / methods
Follow-Up Studies
Humans
Hysteroscopy / methods
Infertility, Female / complications*
Infertility, Female / diagnosis
Infertility, Female / therapy*
Ovulation Induction / adverse effects*
Ovulation Induction / methods
Recurrence
Risk Assessment
Severity of Illness Index
Uterine Hemorrhage / diagnosis
Uterine Hemorrhage / etiology*
Uterine Hemorrhage / therapy
von Willebrand Diseases / complications*
von Willebrand Diseases / diagnosis*
von Willebrand Diseases / therapy
von Willebrand Factor / analysis

Substances

von Willebrand Factor